Manufacturer record

Mfg By: Alencure Bitech Pvt.Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

1 batch manufactured by Mfg By: Alencure Bitech Pvt.Ltd (Haryana) was declared Not of Standard Quality in March 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: BT0324 089A, Moxirid-LB 625 Tablets, Axoxycillin, Potassium Clavulanate & Lactic Acid Bacillus Tablets (exp Mar 2026). State Lab, Drugs Control Laboratory, Telangana (state lab) found it not of standard quality: MISBRANDED The sample is deemed to be misbranded as it is only indicated as approved colur used on the label of the product but failed to. Listed in the March 2025 alert.

Records by type

1 record linked to Mfg By: Alencure Bitech Pvt.Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
1Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Mar 2025 to Mar 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

1
NSQ batches since 2025
1
Products affected
Misbranded
Most common failure
Mar 2025
Latest alert

Flagged batches per year

2025 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Moxirid-LB 625 Tablets, Axoxycillin, Potassium Clavulanate & Lactic Acid Bacillus Tablets Batch BT0324 089AMfg Oct 2024 · Exp Mar 2026 MISBRANDED The sample is deemed to be misbranded as it is only indicated as approved colur used on the label of the product but failed to indicate the common name of the colur on the label as required as per Rule 127(2) of Drugs Rules, 1945. Hence the drug is a Misbranded drug as per Section 17 of Drugs and Cosmetics Act 1940.Misbranded State Lab, Drugs Control Laboratory, TelanganaState lab Mar 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.